158 related articles for article (PubMed ID: 22246196)
1. Tanshinone IIA inhibits human breast cancer MDA-MB-231 cells by decreasing LC3-II, Erb-B2 and NF-κBp65.
Su CC; Chien SY; Kuo SJ; Chen YL; Cheng CY; Chen DR
Mol Med Rep; 2012 Apr; 5(4):1019-22. PubMed ID: 22246196
[TBL] [Abstract][Full Text] [Related]
2. Tanshinone IIA inhibits human hepatocellular carcinoma J5 cell growth by increasing Bax and caspase 3 and decreasing CD31 expression in vivo.
Chien SY; Kuo SJ; Chen YL; Chen DR; Cheng CY; Su CC
Mol Med Rep; 2012 Jan; 5(1):282-6. PubMed ID: 22002472
[TBL] [Abstract][Full Text] [Related]
3. Tanshinone IIA down-regulates the protein expression of ErbB-2 and up-regulates TNF-alpha in colon cancer cells in vitro and in vivo.
Su CC; Lin YH
Int J Mol Med; 2008 Dec; 22(6):847-51. PubMed ID: 19020785
[TBL] [Abstract][Full Text] [Related]
4. Tanshinone IIA affects the malignant growth of Cholangiocarcinoma cells by inhibiting the PI3K-Akt-mTOR pathway.
Liu H; Liu C; Wang M; Sun D; Zhu P; Zhang P; Tan X; Shi G
Sci Rep; 2021 Sep; 11(1):19268. PubMed ID: 34588580
[TBL] [Abstract][Full Text] [Related]
5. Tanshinone IIA inhibits glucose metabolism leading to apoptosis in cervical cancer.
Liu Z; Zhu W; Kong X; Chen X; Sun X; Zhang W; Zhang R
Oncol Rep; 2019 Nov; 42(5):1893-1903. PubMed ID: 31485631
[TBL] [Abstract][Full Text] [Related]
6. Analysis of tanshinone IIA induced cellular apoptosis in leukemia cells by genome-wide expression profiling.
Liu C; Li J; Wang L; Wu F; Huang L; Xu Y; Ye J; Xiao B; Meng F; Chen S; Yang M
BMC Complement Altern Med; 2012 Jan; 12():5. PubMed ID: 22248096
[TBL] [Abstract][Full Text] [Related]
7. Tanshinone IIA inhibits BT-20 human breast cancer cell proliferation through increasing caspase 12, GADD153 and phospho-p38 protein expression.
Yan MY; Chien SY; Kuo SJ; Chen DR; Su CC
Int J Mol Med; 2012 May; 29(5):855-63. PubMed ID: 22322382
[TBL] [Abstract][Full Text] [Related]
8. Tanshinone IIA induces ferroptosis in gastric cancer cells through p53-mediated SLC7A11 down-regulation.
Guan Z; Chen J; Li X; Dong N
Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32776119
[TBL] [Abstract][Full Text] [Related]
9. Tanshinone IIA inhibits human gastric carcinoma AGS cell growth by decreasing BiP, TCTP, Mcl‑1 and Bcl‑xL and increasing Bax and CHOP protein expression.
Su CC
Int J Mol Med; 2014 Dec; 34(6):1661-8. PubMed ID: 25270224
[TBL] [Abstract][Full Text] [Related]
10. Tanshinone IIA inhibits breast cancer stem cells growth in vitro and in vivo through attenuation of IL-6/STAT3/NF-kB signaling pathways.
Lin C; Wang L; Wang H; Yang L; Guo H; Wang X
J Cell Biochem; 2013 Sep; 114(9):2061-70. PubMed ID: 23553622
[TBL] [Abstract][Full Text] [Related]
11. Tanshinone I attenuates the malignant biological properties of ovarian cancer by inducing apoptosis and autophagy via the inactivation of PI3K/AKT/mTOR pathway.
Zhou J; Jiang YY; Chen H; Wu YC; Zhang L
Cell Prolif; 2020 Feb; 53(2):e12739. PubMed ID: 31820522
[TBL] [Abstract][Full Text] [Related]
12. Tanshinone IIA inhibits gastric carcinoma AGS cells through increasing p-p38, p-JNK and p53 but reducing p-ERK, CDC2 and cyclin B1 expression.
Su CC
Anticancer Res; 2014 Dec; 34(12):7097-110. PubMed ID: 25503137
[TBL] [Abstract][Full Text] [Related]
13. Tanshinone IIA inhibits osteosarcoma growth through modulation of AMPK-Nrf2 signaling pathway.
Xie Z; He B; Jiang Z; Zhao L
J Recept Signal Transduct Res; 2020 Dec; 40(6):591-598. PubMed ID: 32496906
[TBL] [Abstract][Full Text] [Related]
14. Experimental study of the anti-cancer mechanism of tanshinone IIA against human breast cancer.
Lu Q; Zhang P; Zhang X; Chen J
Int J Mol Med; 2009 Dec; 24(6):773-80. PubMed ID: 19885617
[TBL] [Abstract][Full Text] [Related]
15. Tanshinone I regulates autophagic signaling via the activation of AMP-activated protein kinase in cancer cells.
Zheng L; Zhang Y; Liu G; Cheng S; Zhang G; An C; Sun S; Wang J; Pang B; Li S
Anticancer Drugs; 2020 Jul; 31(6):601-608. PubMed ID: 32011366
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of Tanshinone II a inhibits malignant melanoma development through blocking autophagy signal transduction in A375 cell.
Li X; Li Z; Li X; Liu B; Liu Z
BMC Cancer; 2017 May; 17(1):357. PubMed ID: 28532456
[TBL] [Abstract][Full Text] [Related]
17. Tanshinone IIA inhibits viral oncogene expression leading to apoptosis and inhibition of cervical cancer.
Munagala R; Aqil F; Jeyabalan J; Gupta RC
Cancer Lett; 2015 Jan; 356(2 Pt B):536-46. PubMed ID: 25304375
[TBL] [Abstract][Full Text] [Related]
18. Potential anticancer activity of tanshinone IIA against human breast cancer.
Wang X; Wei Y; Yuan S; Liu G; Lu Y; Zhang J; Wang W
Int J Cancer; 2005 Sep; 116(5):799-807. PubMed ID: 15849732
[TBL] [Abstract][Full Text] [Related]
19. Tanshinone IIA inhibits Hep-J5 cells by increasing calreticulin, caspase 12 and GADD153 protein expression.
Cheng CY; Su CC
Int J Mol Med; 2010 Sep; 26(3):379-85. PubMed ID: 20664954
[TBL] [Abstract][Full Text] [Related]
20. Tanshinone IIA inhibits gastric carcinoma AGS cells by decreasing the protein expression of VEGFR and blocking Ras/Raf/MEK/ERK pathway.
Su CC
Int J Mol Med; 2018 Apr; 41(4):2389-2396. PubMed ID: 29393362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
